|
Contents
|
|
|
|
Astrocytoma
|
|
|
|
Temozolomide
|
|
|
|
Goldbecker A, Tryc AB, Raab
P, Worthmann H, Herrmann J, Weissenborn K.
Hepatic encephalopathy after treatment with
temozolomide.
J Neurooncol. 2011
May;103(1):163-6. Epub 2010 Aug 22.
.JPG)
Abstract |
.png)
Reprint |
.gif)
Related articles
|
|
|
Momota
H, Nariata Y, Miyakita Y, Hosono A, Makimoto A, Shibui S.
Acute lymphoblastic leukemia after temozolomide treatment for anaplastic
astrocytoma in a child with a germline TP53 mutation
Pediatr Blood Cancer. 2010 Sep;55(3):577-9. Published Online: 22 Apr 2010
Abstract
|
|
|
Glioblastoma |
|
|
|
Bevacizumab
|
|
|
|
Chamberlain
MC, Raizer J, Schiff D, Sherman JH.
Optic neuropathy in patients with glioblastoma receiving bevacizumab
Neurology. 2010 Jul 20;75(3):289-90
Abstract
|
|
|
Higa
GM, Abraham J.
Biological mechanisms of bevacizumab-associated adverse events
Expert Rev Anticancer Ther. 2009 Jul;9(7):999-1007
Abstract
|
|
|
Kelly
PJ, Dinkin MJ, Drappatz J, O'Regan KN, Weiss SE
Unexpected late radiation neurotoxicity following bevacizumab use: a case
series
J Neurooncol. 2010 Aug 1;. [Epub ahead of print]
Abstract
|
|
Methotrexate
|
|
|
|
Price S, Harless W, Rikhye S, Altaha R
A fatal outcome in a patient with glioblastoma multiforme after receiving
high-dose methotrexate
J Oncol Pharm Pract. 2008 Mar;14(1):57-60
Abstract
|
|
Tamoxifen
|
|
|
|
Puchner MJ, Giese A, Lohmann F, Cristante L.
High-dose tamoxifen treatment increases the incidence of multifocal tumor
recurrences in glioblastoma patients
Anticancer Res. 2004 Nov-Dec;24(6):4195-203
|
|
Temozolomide
|
|
|
|
Guilleminault L, Carré P, De Luca K, Beau
Salinas F, Autret-Leca E, Narciso B, Diot P
Alveolo-interstitial pneumonia due to Temozolamide
Rev Mal Respir. 2008
Sep;25(7):880-4
Abstract
|
|
|
Niewald M, Berdel C, Fleckenstein J, Licht N, Ketter R, Rübe C.
Toxicity
after radiochemotherapy for glioblastoma using temozolomide - a
retrospective evaluation.
Radiat Oncol.
2011 Oct 21;6:141.
Abstract |
Reprint |
Related articles
|
|
|
Sijben
AE, McIntyre JB, Roldán GB, Easaw JC, Yan E, Forsyth PA, Parney IF,
Magliocco AM, Bernsen H, Cairncross JG
Toxicity from chemoradiotherapy in older patients with glioblastoma
multiforme
J Neurooncol. 2008 Apr 9;. [Epub ahead of print]
Abstract
|
|
|
Gliomas |
|
|
|
Temozolomide
|
|
|
|
Chamberlain
MC, Raizer J.
Extended exposure to alkylator chemotherapy: delayed appearance of
myelodysplasia
J Neurooncol. 2008 Dec 20; [Epub ahead of print]
Abstract
|
|
|
Natelson
EA, Pyatt D.
Temozolomide-induced myelodysplasia
Adv Hematol. 2010;2010:760402. Published
online 2010 March 4
Abstract |
.png)
Full Text |
Reprint
|
|
|
Sure
D, Dunn I, Norden A, Anderson WS.
Intracerebral hemorrhage secondary to thrombocytopenia in a patient
treated with temozolomide
Clin Neurol Neurosurg. 2010 Apr 29;. [Epub ahead of print]
Abstract
|
|
|
Medulloblastoma |
|
|
|
Cisplatin
|
|
|
|
Fouladi M, Chintagumpala M, Ashley D, Kellie S,
Gururangan S, Hassall T, Gronewold L, Stewart CF, Wallace D, Broniscer A,
Hale GA, Kasow KA, Merchant TE, Morris B, Krasin M, Kun LE, Boyett JM,
Gajjar A.
Amifostine protects against cisplatin-induced ototoxicity in children
with average-risk medulloblastoma
J
Clin Oncol. 2008 Aug 1;26(22):3749-55
Abstract
|
|
Carboplatin
|
|
|
|
Musial-Bright L, Fengler R, Henze G, Hernáiz
Driever P.
Carboplatin
and ototoxicity: hearing loss rates among survivors of childhood
medulloblastoma.
Childs
Nerv Syst. 2010 Oct 8. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Lymphoma |
|
|
|
Temozolomide
|
|
|
|
Sharma
A, Gupta D, Mohanti BK, Thulkar S, Dwary A, Goyal S, Muzumder S, Das P.
Non-Hodgkin lymphoma following temozolomide
Pediatr Blood Cancer. 2009 Jun 16;. [Epub ahead of print]
Abstract
|
|
|
Metastatic
Tumors |
|
|
|
Bevacizumab
|
|
|
|
Kelly
PJ, Dinkin MJ, Drappatz J, O'Regan KN, Weiss SE
Unexpected late radiation neurotoxicity following bevacizumab use: a case
series
J Neurooncol. 2010 Aug 1;. [Epub ahead of print]
Abstract
|
|
|
|
